Vascular Patches Market by Material (Biologic, Synthetic), Application (Open Repair of Abdominal Aortic Aneurysm, Congenital Heart Disease, Carotid Endarterectomy), End User (Hospitals, Ambulatory Surgical Centers) - Global Forecast to 2027
The global vascular patches market is valued at an estimated USD 353 million in 2022 and is projected to reach USD 517 million by 2027, at a CAGR of 7.9% during the forecast period. Market growth is driven by factors such as the rising incidence of CVD, the rise in the volume of surgical procedures, coupled with the increasing adoption of biological patches for vascular surgeries.
“The biologic vascular patches held the largest share of the vascular patches market, by material”
Based on material, the global vascular patches market is segmented into biological and synthetic vascular patches. Biologic vascular patches held a significant share in the market. It is also the fastest-growing material segment in this market. Growth in this segment is primarily driven by the advantages offered by the biologic patches over their synthetic counterparts.
“The vascular bypass surgery segment is the fastest growing segment of the vascular patches market, by application”
Based on application, the vascular patches market is segmented into carotid endarterectomy (CEA), open repair of abdominal aortic aneurysm (AAA), congenital heart diseases, vascular bypass surgery, and other applications. The vascular bypass surgery is expected to witness the fastest growth during the forecast period. The high growth rate of vascular bypass surgery can be attributed to the availability of reimbursement in emerging and developed economies.
“Among the end users, the hospitals segment is anticipated to register the highest growth during the forecast period”
Based on end users, the vascular patches market is segmented into hospitals and ambulatory surgical centers. The hospitals segment is anticipated to witness growth at the highest rate during the forecast period. The growth can be attributed to the increasing number of hospitals offering better healthcare services and infrastructure.
“The Asia Pacific market is expected to grow at the highest CAGR during the forecast period”
The global vascular patches market is segmented into four regions - North America, Europe, the Asia Pacific, and Rest of the World. The Asia Pacific region is expected to witness the highest growth in the vascular patches market during the forecast period. The high growth in this region can primarily be attributed to the large number of target population, and improved healthcare infrastructures in Southeast Asian countries.
The primary interviews conducted for this report can be categorized as follows:
This report provides a detailed picture of the global vascular patches market. It aims at estimating the size and future growth potential of the market across different segments, such as material, application, end user, and region. The report also includes an in-depth competitive analysis of the key market players, along with their company profiles, recent developments, and key market strategies.
Key Benefits of Buying the Report:
The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall vascular patches market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges
“The biologic vascular patches held the largest share of the vascular patches market, by material”
Based on material, the global vascular patches market is segmented into biological and synthetic vascular patches. Biologic vascular patches held a significant share in the market. It is also the fastest-growing material segment in this market. Growth in this segment is primarily driven by the advantages offered by the biologic patches over their synthetic counterparts.
“The vascular bypass surgery segment is the fastest growing segment of the vascular patches market, by application”
Based on application, the vascular patches market is segmented into carotid endarterectomy (CEA), open repair of abdominal aortic aneurysm (AAA), congenital heart diseases, vascular bypass surgery, and other applications. The vascular bypass surgery is expected to witness the fastest growth during the forecast period. The high growth rate of vascular bypass surgery can be attributed to the availability of reimbursement in emerging and developed economies.
“Among the end users, the hospitals segment is anticipated to register the highest growth during the forecast period”
Based on end users, the vascular patches market is segmented into hospitals and ambulatory surgical centers. The hospitals segment is anticipated to witness growth at the highest rate during the forecast period. The growth can be attributed to the increasing number of hospitals offering better healthcare services and infrastructure.
“The Asia Pacific market is expected to grow at the highest CAGR during the forecast period”
The global vascular patches market is segmented into four regions - North America, Europe, the Asia Pacific, and Rest of the World. The Asia Pacific region is expected to witness the highest growth in the vascular patches market during the forecast period. The high growth in this region can primarily be attributed to the large number of target population, and improved healthcare infrastructures in Southeast Asian countries.
The primary interviews conducted for this report can be categorized as follows:
- By Company Type: Tier 1 - 30%, Tier 2 - 45%, and Tier 3 - 25%
- By Designation: C-level - 28%, D-level - 32%, and Others - 40%
- By Region: North America - 35%, Europe - 21%, Asia Pacific - 28%, Rest of the World – 16%
- Baxter International, Inc. (US)
- LeMaitre Vascular, Inc. (US)
- W. L. Gore & Associates, Inc. (US)
- Getinge AB (Sweden)
- B Braun (Germany)
- Artivion, Inc (US)
- Edwards Lifesciences Corporation (US)
- Aziyo Biologics, Inc. (US)
- Terumo Corporation (Japan)
- BD (US)
- Labcor Laborat?rios Ltda. (Brazil)
- VUP Medical (Czech Republic)
- Aegis Lifesciences (India)
- SynkroMax Biotech Pvt. Ltd. (India)
This report provides a detailed picture of the global vascular patches market. It aims at estimating the size and future growth potential of the market across different segments, such as material, application, end user, and region. The report also includes an in-depth competitive analysis of the key market players, along with their company profiles, recent developments, and key market strategies.
Key Benefits of Buying the Report:
The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall vascular patches market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges
1 INTRODUCTION
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS & EXCLUSIONS
1.3 MARKET SCOPE
FIGURE 1 VASCULAR PATCHES MARKET
1.3.1 YEARS CONSIDERED
1.4 CURRENCY CONSIDERED
1.5 STAKEHOLDERS
1.6 SUMMARY OF CHANGES
1.7 LIMITATIONS
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
FIGURE 2 RESEARCH DESIGN
2.1.1 SECONDARY SOURCES
2.1.1.1 Secondary sources
2.1.2 PRIMARY DATA
2.1.2.1 Key data from primary sources
2.1.2.2 Key industry insights
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
2.2 MARKET SIZE ESTIMATION
2.2.1 BOTTOM-UP APPROACH
FIGURE 5 MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH
FIGURE 6 MARKET SIZE ESTIMATION: TOP-DOWN APPROACH
FIGURE 7 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
FIGURE 8 DATA TRIANGULATION METHODOLOGY
2.4 MARKET SHARE ANALYSIS
2.5 STUDY ASSUMPTIONS
2.6 RISK ASSESSMENT
TABLE 1 RISK ASSESSMENT: VASCULAR PATCHES MARKET
2.7 LIMITATIONS
2.7.1 METHODOLOGY-RELATED LIMITATIONS
2.7.2 SCOPE-RELATED LIMITATIONS
2.8 GROWTH RATE ASSUMPTIONS
3 EXECUTIVE SUMMARY
FIGURE 9 VASCULAR PATCHES MARKET, BY MATERIAL, 2022 VS. 2027 (USD MILLION)
FIGURE 10 VASCULAR PATCHES MARKET, BY APPLICATION, 2022 VS. 2027 (USD MILLION)
FIGURE 11 VASCULAR PATCHES MARKET, BY END USER, 2022 VS. 2027 (USD MILLION)
FIGURE 12 GEOGRAPHICAL SNAPSHOT OF VASCULAR PATCHES MARKET
4 PREMIUM INSIGHTS
4.1 VASCULAR PATCHES MARKET OVERVIEW
FIGURE 13 RISING PREVALENCE OF CVD AND GROWING VOLUME OF CARDIOVASCULAR SURGERIES TO DRIVE MARKET
4.2 ASIA PACIFIC: VASCULAR PATCHES MARKET, BY MATERIAL (2021)
FIGURE 14 BIOLOGICAL VASCULAR PATCHES ACCOUNTED FOR LARGEST SHARE IN 2021
4.3 VASCULAR PATCHES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
FIGURE 15 CHINA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD
4.4 VASCULAR PATCHES MARKET: GEOGRAPHIC MIX
FIGURE 16 ASIA PACIFIC MARKET TO WITNESS HIGHEST GROWTH DURING FORECAST PERIOD
4.5 VASCULAR PATCHES MARKET: DEVELOPED VS. EMERGING ECONOMIES
FIGURE 17 EMERGING ECONOMIES TO REGISTER HIGHER GROWTH DURING FORECAST PERIOD
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 18 VASCULAR PATCHES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.2.1 DRIVERS
5.2.1.1 Rising incidence of CVD
5.2.1.2 Growing geriatric population and subsequent prevalence of vascular diseases
5.2.1.3 Rising number of cardiovascular surgeries worldwide
5.2.1.4 Availability of reimbursement for vascular procedures
5.2.1.5 Growing adoption of biological patches
5.2.2 RESTRAINTS
5.2.2.1 High procedural cost of vascular surgeries and associated products
5.2.2.2 Product failures and recalls
5.2.3 OPPORTUNITIES
5.2.3.1 Emerging economies
5.2.3.2 Growth in the number of hospitals & surgical centers
5.2.4 CHALLENGES
5.2.4.1 Lack of skilled professionals
5.3 REGULATORY LANDSCAPE
TABLE 2 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 3 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 4 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 5 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.3.1 NORTH AMERICA
5.3.1.1 US
5.3.1.2 Canada
5.3.2 EUROPE
5.3.3 ASIA PACIFIC
5.3.3.1 China
5.3.3.2 Japan
5.3.3.3 India
5.3.4 LATIN AMERICA
5.3.4.1 Brazil
5.3.4.2 Mexico
5.3.5 MIDDLE EAST
5.3.6 AFRICA
5.4 PORTER’S FIVE FORCES ANALYSIS
TABLE 6 VASCULAR PATCHES MARKET: PORTER’S FIVE FORCES ANALYSIS
5.4.1 THREAT FROM NEW ENTRANTS
5.4.2 THREAT FROM SUBSTITUTES
5.4.3 BARGAINING POWER OF BUYERS
5.4.4 BARGAINING POWER OF SUPPLIERS
5.4.5 DEGREE OF COMPETITION
5.5 TECHNOLOGY ANALYSIS
5.6 VALUE CHAIN ANALYSIS
5.7 SUPPLY CHAIN ANALYSIS
FIGURE 19 VASCULAR PATCHES MARKET: SUPPLY CHAIN ANALYSIS
5.8 ECOSYSTEM ANALYSIS
FIGURE 20 VASCULAR PATCHES MARKET: ECOSYSTEM ANALYSIS
5.8.1 ECOSYSTEM ROLE
6 VASCULAR PATCHES MARKET, BY MATERIAL
6.1 INTRODUCTION
TABLE 7 VASCULAR PATCHES MARKET, BY MATERIAL, 2020–2027 (USD MILLION)
6.2 BIOLOGIC VASCULAR PATCHES
6.2.1 WIDE USAGE IN ARTERIAL CLOSURE DURING CARDIAC SURGERIES TO DRIVE MARKET
TABLE 8 BIOLOGIC VASCULAR PATCHES MARKET, BY REGION, 2020–2027 (USD MILLION)
6.3 SYNTHETIC VASCULAR PATCHES
6.3.1 HIGH RISK OF INFECTION DESPITE BEING COST-EFFICIENT TO RESTRAIN MARKET
TABLE 9 SYNTHETIC VASCULAR PATCHES MARKET, BY REGION, 2020–2027 (USD MILLION)
7 VASCULAR PATCHES MARKET, BY APPLICATION
7.1 INTRODUCTION
TABLE 10 VASCULAR PATCHES MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
7.2 CAROTID ENDARTERECTOMY
7.2.1 INCREASING PATCH ANGIOPLASTY PROCEDURES TO DRIVE MARKET
TABLE 11 VASCULAR PATCHES MARKET FOR CAROTID ENDARTERECTOMY, BY REGION, 2020–2027 (USD MILLION)
7.3 VASCULAR BYPASS SURGERY
7.3.1 RISING PREVALENCE OF VASCULAR DISEASES TO DRIVE MARKET
TABLE 12 VASCULAR PATCHES MARKET FOR VASCULAR BYPASS SURGERY, BY REGION, 2020–2027 (USD MILLION)
7.4 CONGENITAL HEART DISEASE
7.4.1 USE OF SYNTHETIC & BIOLOGIC VASCULAR PATCHES FOR CORRECTIVE SURGERIES TO DRIVE MARKET
TABLE 13 VASCULAR PATCHES MARKET FOR CONGENITAL HEART DISEASE, BY REGION, 2020–2027 (USD MILLION)
7.5 OPEN REPAIR OF ABDOMINAL AORTIC ANEURYSM
7.5.1 RISING INCIDENCE OF AAA TO DRIVE DEMAND FOR VASCULAR PATCHES
TABLE 14 VASCULAR PATCHES MARKET FOR OPEN REPAIR OF ABDOMINAL AORTIC ANEURYSM, BY REGION, 2020–2027 (USD MILLION)
7.6 OTHER APPLICATIONS
TABLE 15 VASCULAR PATCHES MARKET FOR OTHER APPLICATIONS, BY REGION, 2020–2027 (USD MILLION)
8 VASCULAR PATCHES MARKET, BY END USER
8.1 INTRODUCTION
TABLE 16 VASCULAR PATCHES MARKET, BY END USER, 2020–2027 (USD MILLION)
8.2 HOSPITALS
8.2.1 RISING BURDEN OF CVD AND DEVELOPING INFRASTRUCTURE IN EMERGING ECONOMIES TO DRIVE MARKET
TABLE 17 VASCULAR PATCHES MARKET FOR HOSPITALS, BY REGION, 2020–2027 (USD MILLION)
8.3 AMBULATORY SURGICAL CENTERS
8.3.1 RISING NUMBER OF ASCS TO PROPEL MARKET GROWTH
TABLE 18 VASCULAR PATCHES MARKET FOR AMBULATORY SURGICAL CENTERS, BY REGION, 2020–2027 (USD MILLION)
9 VASCULAR PATCHES MARKET, BY REGION
9.1 INTRODUCTION
TABLE 19 VASCULAR PATCHES MARKET, BY REGION, 2020–2027 (USD MILLION)
9.2 NORTH AMERICA
FIGURE 21 NORTH AMERICA: VASCULAR PATCHES MARKET SNAPSHOT
TABLE 20 NORTH AMERICA: VASCULAR PATCHES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 21 NORTH AMERICA: VASCULAR PATCHES MARKET, BY MATERIAL, 2020–2027 (USD MILLION)
TABLE 22 NORTH AMERICA: VASCULAR PATCHES MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 23 NORTH AMERICA: VASCULAR PATCHES MARKET, BY END USER, 2020–2027 (USD MILLION)
9.2.1 US
9.2.1.1 Favorable government reimbursements for vascular surgeries to drive market
TABLE 24 US: VASCULAR PATCHES MARKET, BY MATERIAL, 2020–2027 (USD MILLION)
TABLE 25 US: VASCULAR PATCHES MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 26 US: VASCULAR PATCHES MARKET, BY END USER, 2020–2027 (USD MILLION)
9.2.2 CANADA
9.2.2.1 High incidence of vascular diseases to support market growth
TABLE 27 CANADA: VASCULAR PATCHES MARKET, BY MATERIAL, 2020–2027 (USD MILLION)
TABLE 28 CANADA: VASCULAR PATCHES MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 29 CANADA: VASCULAR PATCHES MARKET, BY END USER, 2020–2027 (USD MILLION)
9.3 EUROPE
TABLE 30 EUROPE: VASCULAR PATCHES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 31 EUROPE: VASCULAR PATCHES MARKET, BY MATERIAL, 2020–2027 (USD MILLION)
TABLE 32 EUROPE: VASCULAR PATCHES MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 33 EUROPE: VASCULAR PATCHES MARKET, BY END USER, 2020–2027 (USD MILLION)
9.3.1 GERMANY
9.3.1.1 Presence of a large target patient population to support market growth
TABLE 34 GERMANY: VASCULAR PATCHES MARKET, BY MATERIAL, 2020–2027 (USD MILLION)
TABLE 35 GERMANY: VASCULAR PATCHES MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 36 GERMANY: VASCULAR PATCHES MARKET, BY END USER, 2020–2027 (USD MILLION)
9.3.2 FRANCE
9.3.2.1 High prevalence of CVD to drive demand for vascular patches
TABLE 37 FRANCE: VASCULAR PATCHES MARKET, BY MATERIAL, 2020–2027 (USD MILLION)
TABLE 38 FRANCE: VASCULAR PATCHES MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 39 FRANCE: VASCULAR PATCHES MARKET, BY END USER, 2020–2027 (USD MILLION)
9.3.3 UK
9.3.3.1 Rising geriatric population and subsequent prevalence of CHD to drive market
TABLE 40 UK: VASCULAR PATCHES MARKET, BY MATERIAL, 2020–2027 (USD MILLION)
TABLE 41 UK: VASCULAR PATCHES MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 42 UK: VASCULAR PATCHES MARKET, BY END USER, 2020–2027 (USD MILLION)
9.3.4 ITALY
9.3.4.1 Increasing incidence of CHD to support market growth
TABLE 43 ITALY: VASCULAR PATCHES MARKET, BY MATERIAL, 2020–2027 (USD MILLION)
TABLE 44 ITALY: VASCULAR PATCHES MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 45 ITALY: VASCULAR PATCHES MARKET, BY END USER, 2020–2027 (USD MILLION)
9.3.5 SPAIN
9.3.5.1 Rising risk of developing CVD due to age-related disorders to support market growth
TABLE 46 SPAIN: VASCULAR PATCHES MARKET, BY MATERIAL, 2020–2027 (USD MILLION)
TABLE 47 SPAIN: VASCULAR PATCHES MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 48 SPAIN: VASCULAR PATCHES MARKET, BY END USER, 2020–2027 (USD MILLION)
9.3.6 REST OF EUROPE
TABLE 49 REST OF EUROPE: VASCULAR PATCHES MARKET, BY MATERIAL, 2020–2027 (USD MILLION)
TABLE 50 REST OF EUROPE: VASCULAR PATCHES MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 51 REST OF EUROPE: VASCULAR PATCHES MARKET, BY END USER, 2020–2027 (USD MILLION)
9.4 ASIA PACIFIC
FIGURE 22 ASIA PACIFIC: VASCULAR PATCHES MARKET SNAPSHOT (2021)
TABLE 52 ASIA PACIFIC: VASCULAR PATCHES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 53 ASIA PACIFIC: VASCULAR PATCHES MARKET, BY MATERIAL, 2020–2027 (USD MILLION)
TABLE 54 ASIA PACIFIC: VASCULAR PATCHES MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 55 ASIA PACIFIC: VASCULAR PATCHES MARKET, BY END USER, 2020–2027 (USD MILLION)
9.4.1 CHINA
9.4.1.1 Rising prevalence of chronic heart diseases to drive market
TABLE 56 CHINA: VASCULAR PATCHES MARKET, BY MATERIAL, 2020–2027 (USD MILLION)
TABLE 57 CHINA: VASCULAR PATCHES MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 58 CHINA: VASCULAR PATCHES MARKET, BY END USER, 2020–2027 (USD MILLION)
9.4.2 JAPAN
9.4.2.1 Rising public healthcare spending to drive demand for vascular patches
TABLE 59 JAPAN: VASCULAR PATCHES MARKET, BY MATERIAL, 2020–2027 (USD MILLION)
TABLE 60 JAPAN: VASCULAR PATCHES MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 61 JAPAN: VASCULAR PATCHES MARKET, BY END USER, 2020–2027 (USD MILLION)
9.4.3 INDIA
9.4.3.1 Rising incidence of CVD to drive market
TABLE 62 INDIA: VASCULAR PATCHES MARKET, BY MATERIAL, 2020–2027 (USD MILLION)
TABLE 63 INDIA: VASCULAR PATCHES MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 64 INDIA: VASCULAR PATCHES MARKET, BY END USER, 2020–2027 (USD MILLION)
9.4.4 REST OF ASIA PACIFIC
TABLE 65 REST OF ASIA PACIFIC: VASCULAR PATCHES MARKET, BY MATERIAL, 2020–2027 (USD MILLION)
TABLE 66 REST OF ASIA PACIFIC: VASCULAR PATCHES MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 67 REST OF ASIA PACIFIC: VASCULAR PATCHES MARKET, BY END USER, 2020–2027 (USD MILLION)
9.5 REST OF THE WORLD
TABLE 68 REST OF THE WORLD: VASCULAR PATCHES MARKET, BY MATERIAL, 2020–2027 (USD MILLION)
TABLE 69 REST OF THE WORLD: VASCULAR PATCHES MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 70 REST OF THE WORLD: VASCULAR PATCHES MARKET, BY END USER, 2020–2027 (USD MILLION)
10 COMPETITIVE LANDSCAPE
10.1 OVERVIEW
10.2 STRATEGIES ADOPTED BY KEY PLAYERS
TABLE 71 OVERVIEW OF STRATEGIES ADOPTED BY KEY MARKET PLAYERS
10.3 REVENUE SHARE ANALYSIS
FIGURE 23 VASCULAR PATCHES MARKET: REVENUE SHARE ANALYSIS OF KEY PLAYERS
10.4 MARKET SHARE ANALYSIS
TABLE 72 VASCULAR PATCHES MARKET: DEGREE OF COMPETITION
FIGURE 24 VASCULAR PATCHES MARKET SHARE ANALYSIS, 2021
10.5 COMPANY EVALUATION QUADRANT
10.5.1 STARS
10.5.2 EMERGING LEADERS
10.5.3 PERVASIVE PLAYERS
10.5.4 PARTICIPANTS
FIGURE 25 VASCULAR PATCHES MARKET: COMPANY EVALUATION QUADRANT (2021)
10.6 COMPANY FOOTPRINT ANALYSIS
TABLE 73 COMPANY FOOTPRINT
TABLE 74 COMPANY MATERIAL FOOTPRINT
TABLE 75 COMPANY REGIONAL FOOTPRINT
10.7 COMPETITIVE SCENARIO
10.7.1 DEALS
TABLE 76 VASCULAR PATCHES MARKET: DEALS, 2019–2022
10.7.2 OTHER DEVELOPMENTS
TABLE 77 VASCULAR PATCHES MARKET: OTHER DEVELOPMENTS, 2019–2022
11 COMPANY PROFILES
(Business Overview, Products/Solutions/Services Offered, Recent Developments, MnM view (Key strengths/Right to win, Strategic choices made, Weakness/competitive threats)*
11.1 KEY PLAYERS
11.1.1 BAXTER INTERNATIONAL, INC.
TABLE 78 BAXTER INTERNATIONAL, INC: COMPANY OVERVIEW
FIGURE 26 BAXTER INTERNATIONAL, INC: COMPANY SNAPSHOT (2021)
11.1.2 LEMAITRE VASCULAR, INC.
TABLE 79 LEMAITRE VASCULAR, INC: COMPANY OVERVIEW
FIGURE 27 LEMAITRE VASCULAR, INC: COMPANY SNAPSHOT (2021)
11.1.3 W. L. GORE & ASSOCIATES, INC.
TABLE 80 W. L. GORE & ASSOCIATES: COMPANY OVERVIEW
11.1.4 GETINGE AB
TABLE 81 GETINGE AB: COMPANY OVERVIEW
FIGURE 28 GETINGE AB: COMPANY SNAPSHOT (2021)
TABLE 82 EXCHANGE RATES UTILIZED FOR CONVERSION OF SEK TO USD
11.1.5 B. BRAUN
TABLE 83 B. BRAUN: COMPANY OVERVIEW
FIGURE 29 B. BRAUN: COMPANY SNAPSHOT (2021)
TABLE 84 EXCHANGE RATES UTILIZED FOR CONVERSION OF EUROS TO USD
11.1.6 EDWARDS LIFESCIENCES CORPORATION
TABLE 85 EDWARDS LIFESCIENCES CORPORATION: COMPANY OVERVIEW
FIGURE 30 EDWARDS LIFESCIENCES CORPORATION: COMPANY SNAPSHOT (2021)
11.1.7 BECTON, DICKINSON AND COMPANY
TABLE 86 BECTON, DICKINSON AND COMPANY: COMPANY OVERVIEW
FIGURE 31 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2021)
11.1.8 AZIYO BIOLOGICS, INC.
TABLE 87 AZIYO BIOLOGICS, INC: COMPANY OVERVIEW
FIGURE 32 AZIYO BIOLOGICS, INC: COMPANY SNAPSHOT (2021)
11.1.9 TERUMO CORPORATION
TABLE 88 TERUMO CORPORATION: COMPANY OVERVIEW
FIGURE 33 TERUMO CORPORATION: COMPANY SNAPSHOT (2022)
TABLE 89 EXCHANGE RATES UTILIZED FOR CONVERSION OF YEN TO USD
11.1.10 ARTIVION, INC.
TABLE 90 ARTIVION, INC.: COMPANY OVERVIEW
FIGURE 34 ARTIVION, INC: COMPANY SNAPSHOT (2021)
11.1.11 LABCOR LABORAT?RIOS LTDA.
TABLE 91 LABCOR LABORAT?RIOS LTDA.: COMPANY OVERVIEW
11.2 OTHER PLAYERS
11.2.1 VUP MEDICAL
TABLE 92 VUP MEDICAL: COMPANY OVERVIEW
11.2.2 AEGIS LIFESCIENCES
TABLE 93 AEGIS LIFESCIENCES: COMPANY OVERVIEW
11.2.3 SYNKROMAX BIOTECH PVT. LTD.
TABLE 94 SYNKROMAX BIOTECH PVT. LTD: COMPANY OVERVIEW
*Details on Business Overview, Products/Solutions/Services Offered, Recent Developments, MnM view (Key strengths/Right to win, Strategic choices made, Weakness/competitive threats)* might not be captured in case of unlisted companies.
12 APPENDIX
12.1 INDUSTRY EXPERT INSIGHTS
12.2 DISCUSSION GUIDE
12.3 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
12.4 CUSTOMIZATION OPTIONS
12.5 RELATED REPORTS
12.6 AUTHOR DETAILS
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS & EXCLUSIONS
1.3 MARKET SCOPE
FIGURE 1 VASCULAR PATCHES MARKET
1.3.1 YEARS CONSIDERED
1.4 CURRENCY CONSIDERED
1.5 STAKEHOLDERS
1.6 SUMMARY OF CHANGES
1.7 LIMITATIONS
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
FIGURE 2 RESEARCH DESIGN
2.1.1 SECONDARY SOURCES
2.1.1.1 Secondary sources
2.1.2 PRIMARY DATA
2.1.2.1 Key data from primary sources
2.1.2.2 Key industry insights
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
2.2 MARKET SIZE ESTIMATION
2.2.1 BOTTOM-UP APPROACH
FIGURE 5 MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH
FIGURE 6 MARKET SIZE ESTIMATION: TOP-DOWN APPROACH
FIGURE 7 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
FIGURE 8 DATA TRIANGULATION METHODOLOGY
2.4 MARKET SHARE ANALYSIS
2.5 STUDY ASSUMPTIONS
2.6 RISK ASSESSMENT
TABLE 1 RISK ASSESSMENT: VASCULAR PATCHES MARKET
2.7 LIMITATIONS
2.7.1 METHODOLOGY-RELATED LIMITATIONS
2.7.2 SCOPE-RELATED LIMITATIONS
2.8 GROWTH RATE ASSUMPTIONS
3 EXECUTIVE SUMMARY
FIGURE 9 VASCULAR PATCHES MARKET, BY MATERIAL, 2022 VS. 2027 (USD MILLION)
FIGURE 10 VASCULAR PATCHES MARKET, BY APPLICATION, 2022 VS. 2027 (USD MILLION)
FIGURE 11 VASCULAR PATCHES MARKET, BY END USER, 2022 VS. 2027 (USD MILLION)
FIGURE 12 GEOGRAPHICAL SNAPSHOT OF VASCULAR PATCHES MARKET
4 PREMIUM INSIGHTS
4.1 VASCULAR PATCHES MARKET OVERVIEW
FIGURE 13 RISING PREVALENCE OF CVD AND GROWING VOLUME OF CARDIOVASCULAR SURGERIES TO DRIVE MARKET
4.2 ASIA PACIFIC: VASCULAR PATCHES MARKET, BY MATERIAL (2021)
FIGURE 14 BIOLOGICAL VASCULAR PATCHES ACCOUNTED FOR LARGEST SHARE IN 2021
4.3 VASCULAR PATCHES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
FIGURE 15 CHINA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD
4.4 VASCULAR PATCHES MARKET: GEOGRAPHIC MIX
FIGURE 16 ASIA PACIFIC MARKET TO WITNESS HIGHEST GROWTH DURING FORECAST PERIOD
4.5 VASCULAR PATCHES MARKET: DEVELOPED VS. EMERGING ECONOMIES
FIGURE 17 EMERGING ECONOMIES TO REGISTER HIGHER GROWTH DURING FORECAST PERIOD
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 18 VASCULAR PATCHES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.2.1 DRIVERS
5.2.1.1 Rising incidence of CVD
5.2.1.2 Growing geriatric population and subsequent prevalence of vascular diseases
5.2.1.3 Rising number of cardiovascular surgeries worldwide
5.2.1.4 Availability of reimbursement for vascular procedures
5.2.1.5 Growing adoption of biological patches
5.2.2 RESTRAINTS
5.2.2.1 High procedural cost of vascular surgeries and associated products
5.2.2.2 Product failures and recalls
5.2.3 OPPORTUNITIES
5.2.3.1 Emerging economies
5.2.3.2 Growth in the number of hospitals & surgical centers
5.2.4 CHALLENGES
5.2.4.1 Lack of skilled professionals
5.3 REGULATORY LANDSCAPE
TABLE 2 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 3 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 4 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 5 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.3.1 NORTH AMERICA
5.3.1.1 US
5.3.1.2 Canada
5.3.2 EUROPE
5.3.3 ASIA PACIFIC
5.3.3.1 China
5.3.3.2 Japan
5.3.3.3 India
5.3.4 LATIN AMERICA
5.3.4.1 Brazil
5.3.4.2 Mexico
5.3.5 MIDDLE EAST
5.3.6 AFRICA
5.4 PORTER’S FIVE FORCES ANALYSIS
TABLE 6 VASCULAR PATCHES MARKET: PORTER’S FIVE FORCES ANALYSIS
5.4.1 THREAT FROM NEW ENTRANTS
5.4.2 THREAT FROM SUBSTITUTES
5.4.3 BARGAINING POWER OF BUYERS
5.4.4 BARGAINING POWER OF SUPPLIERS
5.4.5 DEGREE OF COMPETITION
5.5 TECHNOLOGY ANALYSIS
5.6 VALUE CHAIN ANALYSIS
5.7 SUPPLY CHAIN ANALYSIS
FIGURE 19 VASCULAR PATCHES MARKET: SUPPLY CHAIN ANALYSIS
5.8 ECOSYSTEM ANALYSIS
FIGURE 20 VASCULAR PATCHES MARKET: ECOSYSTEM ANALYSIS
5.8.1 ECOSYSTEM ROLE
6 VASCULAR PATCHES MARKET, BY MATERIAL
6.1 INTRODUCTION
TABLE 7 VASCULAR PATCHES MARKET, BY MATERIAL, 2020–2027 (USD MILLION)
6.2 BIOLOGIC VASCULAR PATCHES
6.2.1 WIDE USAGE IN ARTERIAL CLOSURE DURING CARDIAC SURGERIES TO DRIVE MARKET
TABLE 8 BIOLOGIC VASCULAR PATCHES MARKET, BY REGION, 2020–2027 (USD MILLION)
6.3 SYNTHETIC VASCULAR PATCHES
6.3.1 HIGH RISK OF INFECTION DESPITE BEING COST-EFFICIENT TO RESTRAIN MARKET
TABLE 9 SYNTHETIC VASCULAR PATCHES MARKET, BY REGION, 2020–2027 (USD MILLION)
7 VASCULAR PATCHES MARKET, BY APPLICATION
7.1 INTRODUCTION
TABLE 10 VASCULAR PATCHES MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
7.2 CAROTID ENDARTERECTOMY
7.2.1 INCREASING PATCH ANGIOPLASTY PROCEDURES TO DRIVE MARKET
TABLE 11 VASCULAR PATCHES MARKET FOR CAROTID ENDARTERECTOMY, BY REGION, 2020–2027 (USD MILLION)
7.3 VASCULAR BYPASS SURGERY
7.3.1 RISING PREVALENCE OF VASCULAR DISEASES TO DRIVE MARKET
TABLE 12 VASCULAR PATCHES MARKET FOR VASCULAR BYPASS SURGERY, BY REGION, 2020–2027 (USD MILLION)
7.4 CONGENITAL HEART DISEASE
7.4.1 USE OF SYNTHETIC & BIOLOGIC VASCULAR PATCHES FOR CORRECTIVE SURGERIES TO DRIVE MARKET
TABLE 13 VASCULAR PATCHES MARKET FOR CONGENITAL HEART DISEASE, BY REGION, 2020–2027 (USD MILLION)
7.5 OPEN REPAIR OF ABDOMINAL AORTIC ANEURYSM
7.5.1 RISING INCIDENCE OF AAA TO DRIVE DEMAND FOR VASCULAR PATCHES
TABLE 14 VASCULAR PATCHES MARKET FOR OPEN REPAIR OF ABDOMINAL AORTIC ANEURYSM, BY REGION, 2020–2027 (USD MILLION)
7.6 OTHER APPLICATIONS
TABLE 15 VASCULAR PATCHES MARKET FOR OTHER APPLICATIONS, BY REGION, 2020–2027 (USD MILLION)
8 VASCULAR PATCHES MARKET, BY END USER
8.1 INTRODUCTION
TABLE 16 VASCULAR PATCHES MARKET, BY END USER, 2020–2027 (USD MILLION)
8.2 HOSPITALS
8.2.1 RISING BURDEN OF CVD AND DEVELOPING INFRASTRUCTURE IN EMERGING ECONOMIES TO DRIVE MARKET
TABLE 17 VASCULAR PATCHES MARKET FOR HOSPITALS, BY REGION, 2020–2027 (USD MILLION)
8.3 AMBULATORY SURGICAL CENTERS
8.3.1 RISING NUMBER OF ASCS TO PROPEL MARKET GROWTH
TABLE 18 VASCULAR PATCHES MARKET FOR AMBULATORY SURGICAL CENTERS, BY REGION, 2020–2027 (USD MILLION)
9 VASCULAR PATCHES MARKET, BY REGION
9.1 INTRODUCTION
TABLE 19 VASCULAR PATCHES MARKET, BY REGION, 2020–2027 (USD MILLION)
9.2 NORTH AMERICA
FIGURE 21 NORTH AMERICA: VASCULAR PATCHES MARKET SNAPSHOT
TABLE 20 NORTH AMERICA: VASCULAR PATCHES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 21 NORTH AMERICA: VASCULAR PATCHES MARKET, BY MATERIAL, 2020–2027 (USD MILLION)
TABLE 22 NORTH AMERICA: VASCULAR PATCHES MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 23 NORTH AMERICA: VASCULAR PATCHES MARKET, BY END USER, 2020–2027 (USD MILLION)
9.2.1 US
9.2.1.1 Favorable government reimbursements for vascular surgeries to drive market
TABLE 24 US: VASCULAR PATCHES MARKET, BY MATERIAL, 2020–2027 (USD MILLION)
TABLE 25 US: VASCULAR PATCHES MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 26 US: VASCULAR PATCHES MARKET, BY END USER, 2020–2027 (USD MILLION)
9.2.2 CANADA
9.2.2.1 High incidence of vascular diseases to support market growth
TABLE 27 CANADA: VASCULAR PATCHES MARKET, BY MATERIAL, 2020–2027 (USD MILLION)
TABLE 28 CANADA: VASCULAR PATCHES MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 29 CANADA: VASCULAR PATCHES MARKET, BY END USER, 2020–2027 (USD MILLION)
9.3 EUROPE
TABLE 30 EUROPE: VASCULAR PATCHES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 31 EUROPE: VASCULAR PATCHES MARKET, BY MATERIAL, 2020–2027 (USD MILLION)
TABLE 32 EUROPE: VASCULAR PATCHES MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 33 EUROPE: VASCULAR PATCHES MARKET, BY END USER, 2020–2027 (USD MILLION)
9.3.1 GERMANY
9.3.1.1 Presence of a large target patient population to support market growth
TABLE 34 GERMANY: VASCULAR PATCHES MARKET, BY MATERIAL, 2020–2027 (USD MILLION)
TABLE 35 GERMANY: VASCULAR PATCHES MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 36 GERMANY: VASCULAR PATCHES MARKET, BY END USER, 2020–2027 (USD MILLION)
9.3.2 FRANCE
9.3.2.1 High prevalence of CVD to drive demand for vascular patches
TABLE 37 FRANCE: VASCULAR PATCHES MARKET, BY MATERIAL, 2020–2027 (USD MILLION)
TABLE 38 FRANCE: VASCULAR PATCHES MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 39 FRANCE: VASCULAR PATCHES MARKET, BY END USER, 2020–2027 (USD MILLION)
9.3.3 UK
9.3.3.1 Rising geriatric population and subsequent prevalence of CHD to drive market
TABLE 40 UK: VASCULAR PATCHES MARKET, BY MATERIAL, 2020–2027 (USD MILLION)
TABLE 41 UK: VASCULAR PATCHES MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 42 UK: VASCULAR PATCHES MARKET, BY END USER, 2020–2027 (USD MILLION)
9.3.4 ITALY
9.3.4.1 Increasing incidence of CHD to support market growth
TABLE 43 ITALY: VASCULAR PATCHES MARKET, BY MATERIAL, 2020–2027 (USD MILLION)
TABLE 44 ITALY: VASCULAR PATCHES MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 45 ITALY: VASCULAR PATCHES MARKET, BY END USER, 2020–2027 (USD MILLION)
9.3.5 SPAIN
9.3.5.1 Rising risk of developing CVD due to age-related disorders to support market growth
TABLE 46 SPAIN: VASCULAR PATCHES MARKET, BY MATERIAL, 2020–2027 (USD MILLION)
TABLE 47 SPAIN: VASCULAR PATCHES MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 48 SPAIN: VASCULAR PATCHES MARKET, BY END USER, 2020–2027 (USD MILLION)
9.3.6 REST OF EUROPE
TABLE 49 REST OF EUROPE: VASCULAR PATCHES MARKET, BY MATERIAL, 2020–2027 (USD MILLION)
TABLE 50 REST OF EUROPE: VASCULAR PATCHES MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 51 REST OF EUROPE: VASCULAR PATCHES MARKET, BY END USER, 2020–2027 (USD MILLION)
9.4 ASIA PACIFIC
FIGURE 22 ASIA PACIFIC: VASCULAR PATCHES MARKET SNAPSHOT (2021)
TABLE 52 ASIA PACIFIC: VASCULAR PATCHES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 53 ASIA PACIFIC: VASCULAR PATCHES MARKET, BY MATERIAL, 2020–2027 (USD MILLION)
TABLE 54 ASIA PACIFIC: VASCULAR PATCHES MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 55 ASIA PACIFIC: VASCULAR PATCHES MARKET, BY END USER, 2020–2027 (USD MILLION)
9.4.1 CHINA
9.4.1.1 Rising prevalence of chronic heart diseases to drive market
TABLE 56 CHINA: VASCULAR PATCHES MARKET, BY MATERIAL, 2020–2027 (USD MILLION)
TABLE 57 CHINA: VASCULAR PATCHES MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 58 CHINA: VASCULAR PATCHES MARKET, BY END USER, 2020–2027 (USD MILLION)
9.4.2 JAPAN
9.4.2.1 Rising public healthcare spending to drive demand for vascular patches
TABLE 59 JAPAN: VASCULAR PATCHES MARKET, BY MATERIAL, 2020–2027 (USD MILLION)
TABLE 60 JAPAN: VASCULAR PATCHES MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 61 JAPAN: VASCULAR PATCHES MARKET, BY END USER, 2020–2027 (USD MILLION)
9.4.3 INDIA
9.4.3.1 Rising incidence of CVD to drive market
TABLE 62 INDIA: VASCULAR PATCHES MARKET, BY MATERIAL, 2020–2027 (USD MILLION)
TABLE 63 INDIA: VASCULAR PATCHES MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 64 INDIA: VASCULAR PATCHES MARKET, BY END USER, 2020–2027 (USD MILLION)
9.4.4 REST OF ASIA PACIFIC
TABLE 65 REST OF ASIA PACIFIC: VASCULAR PATCHES MARKET, BY MATERIAL, 2020–2027 (USD MILLION)
TABLE 66 REST OF ASIA PACIFIC: VASCULAR PATCHES MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 67 REST OF ASIA PACIFIC: VASCULAR PATCHES MARKET, BY END USER, 2020–2027 (USD MILLION)
9.5 REST OF THE WORLD
TABLE 68 REST OF THE WORLD: VASCULAR PATCHES MARKET, BY MATERIAL, 2020–2027 (USD MILLION)
TABLE 69 REST OF THE WORLD: VASCULAR PATCHES MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 70 REST OF THE WORLD: VASCULAR PATCHES MARKET, BY END USER, 2020–2027 (USD MILLION)
10 COMPETITIVE LANDSCAPE
10.1 OVERVIEW
10.2 STRATEGIES ADOPTED BY KEY PLAYERS
TABLE 71 OVERVIEW OF STRATEGIES ADOPTED BY KEY MARKET PLAYERS
10.3 REVENUE SHARE ANALYSIS
FIGURE 23 VASCULAR PATCHES MARKET: REVENUE SHARE ANALYSIS OF KEY PLAYERS
10.4 MARKET SHARE ANALYSIS
TABLE 72 VASCULAR PATCHES MARKET: DEGREE OF COMPETITION
FIGURE 24 VASCULAR PATCHES MARKET SHARE ANALYSIS, 2021
10.5 COMPANY EVALUATION QUADRANT
10.5.1 STARS
10.5.2 EMERGING LEADERS
10.5.3 PERVASIVE PLAYERS
10.5.4 PARTICIPANTS
FIGURE 25 VASCULAR PATCHES MARKET: COMPANY EVALUATION QUADRANT (2021)
10.6 COMPANY FOOTPRINT ANALYSIS
TABLE 73 COMPANY FOOTPRINT
TABLE 74 COMPANY MATERIAL FOOTPRINT
TABLE 75 COMPANY REGIONAL FOOTPRINT
10.7 COMPETITIVE SCENARIO
10.7.1 DEALS
TABLE 76 VASCULAR PATCHES MARKET: DEALS, 2019–2022
10.7.2 OTHER DEVELOPMENTS
TABLE 77 VASCULAR PATCHES MARKET: OTHER DEVELOPMENTS, 2019–2022
11 COMPANY PROFILES
(Business Overview, Products/Solutions/Services Offered, Recent Developments, MnM view (Key strengths/Right to win, Strategic choices made, Weakness/competitive threats)*
11.1 KEY PLAYERS
11.1.1 BAXTER INTERNATIONAL, INC.
TABLE 78 BAXTER INTERNATIONAL, INC: COMPANY OVERVIEW
FIGURE 26 BAXTER INTERNATIONAL, INC: COMPANY SNAPSHOT (2021)
11.1.2 LEMAITRE VASCULAR, INC.
TABLE 79 LEMAITRE VASCULAR, INC: COMPANY OVERVIEW
FIGURE 27 LEMAITRE VASCULAR, INC: COMPANY SNAPSHOT (2021)
11.1.3 W. L. GORE & ASSOCIATES, INC.
TABLE 80 W. L. GORE & ASSOCIATES: COMPANY OVERVIEW
11.1.4 GETINGE AB
TABLE 81 GETINGE AB: COMPANY OVERVIEW
FIGURE 28 GETINGE AB: COMPANY SNAPSHOT (2021)
TABLE 82 EXCHANGE RATES UTILIZED FOR CONVERSION OF SEK TO USD
11.1.5 B. BRAUN
TABLE 83 B. BRAUN: COMPANY OVERVIEW
FIGURE 29 B. BRAUN: COMPANY SNAPSHOT (2021)
TABLE 84 EXCHANGE RATES UTILIZED FOR CONVERSION OF EUROS TO USD
11.1.6 EDWARDS LIFESCIENCES CORPORATION
TABLE 85 EDWARDS LIFESCIENCES CORPORATION: COMPANY OVERVIEW
FIGURE 30 EDWARDS LIFESCIENCES CORPORATION: COMPANY SNAPSHOT (2021)
11.1.7 BECTON, DICKINSON AND COMPANY
TABLE 86 BECTON, DICKINSON AND COMPANY: COMPANY OVERVIEW
FIGURE 31 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2021)
11.1.8 AZIYO BIOLOGICS, INC.
TABLE 87 AZIYO BIOLOGICS, INC: COMPANY OVERVIEW
FIGURE 32 AZIYO BIOLOGICS, INC: COMPANY SNAPSHOT (2021)
11.1.9 TERUMO CORPORATION
TABLE 88 TERUMO CORPORATION: COMPANY OVERVIEW
FIGURE 33 TERUMO CORPORATION: COMPANY SNAPSHOT (2022)
TABLE 89 EXCHANGE RATES UTILIZED FOR CONVERSION OF YEN TO USD
11.1.10 ARTIVION, INC.
TABLE 90 ARTIVION, INC.: COMPANY OVERVIEW
FIGURE 34 ARTIVION, INC: COMPANY SNAPSHOT (2021)
11.1.11 LABCOR LABORAT?RIOS LTDA.
TABLE 91 LABCOR LABORAT?RIOS LTDA.: COMPANY OVERVIEW
11.2 OTHER PLAYERS
11.2.1 VUP MEDICAL
TABLE 92 VUP MEDICAL: COMPANY OVERVIEW
11.2.2 AEGIS LIFESCIENCES
TABLE 93 AEGIS LIFESCIENCES: COMPANY OVERVIEW
11.2.3 SYNKROMAX BIOTECH PVT. LTD.
TABLE 94 SYNKROMAX BIOTECH PVT. LTD: COMPANY OVERVIEW
*Details on Business Overview, Products/Solutions/Services Offered, Recent Developments, MnM view (Key strengths/Right to win, Strategic choices made, Weakness/competitive threats)* might not be captured in case of unlisted companies.
12 APPENDIX
12.1 INDUSTRY EXPERT INSIGHTS
12.2 DISCUSSION GUIDE
12.3 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
12.4 CUSTOMIZATION OPTIONS
12.5 RELATED REPORTS
12.6 AUTHOR DETAILS
